Advertisement
Canada markets close in 44 minutes

  • S&P/TSX

    21,787.94
    +79.50 (+0.37%)
     

  • S&P 500

    4,965.07
    -46.05 (-0.92%)
     

  • DOW

    37,930.92
    +155.54 (+0.41%)
     

  • CAD/USD

    0.7276
    +0.0012 (+0.17%)
     

  • CRUDE OIL

    83.41
    +0.68 (+0.82%)
     

  • Bitcoin CAD

    88,505.06
    +1,541.64 (+1.77%)
     

  • CMC Crypto 200

    1,381.29
    +68.67 (+5.23%)
     

  • GOLD FUTURES

    2,410.00
    +12.00 (+0.50%)
     

  • RUSSELL 2000

    1,934.35
    -8.61 (-0.44%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • NASDAQ

    15,277.49
    -324.01 (-2.08%)
     

  • VOLATILITY

    19.12
    +1.12 (+6.22%)
     

  • FTSE

    7,895.85
    +18.80 (+0.24%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6825
    +0.0004 (+0.06%)
     
MARKETS LIVE BLOG:

S&P 500 SLIPS BELOW 5,000; NASDAQ SINKS ON NETFLIX DRAG

Fed's Goolsbee says 'It makes sense to wait' before cutting rates

Top Ranked Momentum Stocks to Buy for August 12th

Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 12th:

ACADIA Pharmaceuticals Inc. (ACAD): This biopharmaceutical companyhas a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.

ACADIA Pharmaceuticals Inc. Price and Consensus

ACADIA Pharmaceuticals Inc. Price and Consensus
ACADIA Pharmaceuticals Inc. Price and Consensus

ACADIA Pharmaceuticals Inc. price-consensus-chart | ACADIA Pharmaceuticals Inc. Quote

ACADIA's shares gained 12% over the last one month compared to S&P 500’s fall of -3.2%. The company possesses a Momentum Score of B.

ADVERTISEMENT

ACADIA Pharmaceuticals Inc. Price

ACADIA Pharmaceuticals Inc. Price
ACADIA Pharmaceuticals Inc. Price

ACADIA Pharmaceuticals Inc. price | ACADIA Pharmaceuticals Inc. Quote

Biogen Inc. (BIIB): This developer of innovative therapies for treating serious neurological and neurodegenerative diseases has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8% over the last 60 days.

Biogen Inc. Price and Consensus

Biogen Inc. Price and Consensus
Biogen Inc. Price and Consensus

Biogen Inc. price-consensus-chart | Biogen Inc. Quote

Biogen's shares gained 0.9% over the last one month. The company possesses a Momentum Score of A.

Biogen Inc. Price

Biogen Inc. Price
Biogen Inc. Price

Biogen Inc. price | Biogen Inc. Quote

AerCap Holdings N.V. (AER): This aircraft leasing company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.7% over the last 60 days.

Aercap Holdings N.V. Price and Consensus

Aercap Holdings N.V. Price and Consensus
Aercap Holdings N.V. Price and Consensus

Aercap Holdings N.V. price-consensus-chart | Aercap Holdings N.V. Quote

AerCap’s shares gained 4.3% over the last one month. The company possesses a Momentum Score of A.

Aercap Holdings N.V. Price

Aercap Holdings N.V. Price
Aercap Holdings N.V. Price

Aercap Holdings N.V. price | Aercap Holdings N.V. Quote

Alamos Gold Inc. (AGI): This explorer and developer of gold deposits has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 58.3% over the last 60 days.

Alamos Gold Inc. Price and Consensus

Alamos Gold Inc. Price and Consensus
Alamos Gold Inc. Price and Consensus

Alamos Gold Inc. price-consensus-chart | Alamos Gold Inc. Quote

Alamos Gold’s shares gained 16.2% over the last one month. The company possesses a Momentum Score of A.

Alamos Gold Inc. Price

Alamos Gold Inc. Price
Alamos Gold Inc. Price

Alamos Gold Inc. price | Alamos Gold Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.

This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.

See their latest picks free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Biogen Inc. (BIIB) : Free Stock Analysis Report
 
Alamos Gold Inc. (AGI) : Free Stock Analysis Report
 
Aercap Holdings N.V. (AER) : Free Stock Analysis Report
 
ACADIA Pharmaceuticals Inc. (ACAD) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research